Autoantibody Standardization in the Netherlands
نویسندگان
چکیده
منابع مشابه
Bilirubin standardization in the Netherlands: alignment within and between manufacturers.
In 2008, two manufacturers lowered the values of their bilirubin calibrators: Abbott Laboratories by 18% and Roche by 10%–17% (different values per instrument). Beckman Coulter, Siemens/Bayer, and Siemens/Dade Behring did not restandardize their methods. In 2009, the Dutch External Quality Assessment Organization in Medical Laboratories [Stichting Kwaliteitsbewaking Medische Laboratoria (SKML)]...
متن کاملStandardization of autoantibody testing: a paradigm for serology in rheumatic diseases
Autoantibody measurement is an excellent tool to confirm the diagnosis of rheumatic autoimmune diseases. Hence, reliability and harmonization of autoantibody testing are essential, but these issues are still a matter of debate. Intrinsic variability in analytes and reagents as well as heterogeneity of the techniques are the main reasons for discrepancies in inter-laboratory variations and repor...
متن کاملStandardization of autoantibody testing: a paradigm for serology in rheumatic diseases
Autoantibody measurement is an excellent tool to confirm the diagnosis of rheumatic autoimmune diseases. Hence, reliability and harmonization of autoantibody testing are essential, but these issues are still a matter of debate. Intrinsic variability in analytes and reagents as well as heterogeneity of the techniques are the main reasons for discrepancies in inter-laboratory variations and repor...
متن کاملthe u.s. policy in central asia and its impact on the colored revolutions in the region (the case study of tulip revolution in kyrgyzstan)
چکیده ندارد.
15 صفحه اولProviders and Patients Caught Between Standardization and Individualization: Individualized Standardization as a Solution; Comment on “(Re) Making the Procrustean Bed? Standardization and Customization as Competing Logics in Healthcare”
In their 2017 article, Mannion and Exworthy provide a thoughtful and theory-based analysis of two parallel trends in modern healthcare systems and their competing and conflicting logics: standardization and customization. This commentary further discusses the challenge of treatment decision-making in times of evidence-based medicine (EBM), shared decision-making and personalized medicine. From ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of the New York Academy of Sciences
سال: 2009
ISSN: 0077-8923,1749-6632
DOI: 10.1111/j.1749-6632.2009.04631.x